Literature DB >> 33574231

Refinement of prognosis and the effect of azacitidine in intermediate-risk myelodysplastic syndromes.

Konstantinos Liapis1, Vasileios Papadopoulos2, George Vrachiolias2, Athanasios G Galanopoulos3, Menelaos Papoutselis2, Sotirios G Papageorgiou4, Panagiotis T Diamantopoulos5, Vassiliki Pappa4, Nora-Athina Viniou5, Alexandra Kourakli6, Dimitris Τsokanas3, Theodoros P Vassilakopoulos7, Eleftheria Hatzimichael8, Eleni Bouronikou9, Maria Ximeri10, Charalambos Pontikoglou10, Aekaterini Megalakaki11, Panagiotis Zikos12, Panayiotis Panayiotidis13, Maria Dimou13, Stamatis Karakatsanis14, Maria Papaioannou15, Anna Vardi16, Flora Kontopidou17, Nikolaos Harchalakis18, Ioannis Adamopoulos19, Argiris Symeonidis6, Ioannis Kotsianidis2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33574231      PMCID: PMC7878783          DOI: 10.1038/s41408-021-00424-4

Source DB:  PubMed          Journal:  Blood Cancer J        ISSN: 2044-5385            Impact factor:   11.037


× No keyword cloud information.
  11 in total

1.  EASIX in patients with acute graft-versus-host disease: a retrospective cohort analysis.

Authors:  Thomas Luft; Axel Benner; Sonata Jodele; Christopher E Dandoy; Rainer Storb; Ted Gooley; Brenda M Sandmaier; Natalia Becker; Aleksandar Radujkovic; Peter Dreger; Olaf Penack
Journal:  Lancet Haematol       Date:  2017-07-18       Impact factor: 18.959

Review 2.  Treatment of MDS.

Authors:  Uwe Platzbecker
Journal:  Blood       Date:  2019-01-22       Impact factor: 22.113

3.  Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents.

Authors:  Sophie Park; Jean-François Hamel; Andrea Toma; Charikleia Kelaidi; Sylvain Thépot; Maria Diez Campelo; Valeria Santini; Mikkael A Sekeres; Enrico Balleari; Jennifer Kaivers; Rosa Sapena; Katharina Götze; Catharina Müller-Thomas; Odile Beyne-Rauzy; Aspasia Stamatoullas; Ioannis Kotsianidis; Rami Komrokji; David P Steensma; Jaime Fensterl; Gail J Roboz; Teresa Bernal; Fernando Ramos; Marisa Calabuig; Agnès Guerci-Bresler; Dominique Bordessoule; Pascale Cony-Makhoul; Stéphane Cheze; Eric Wattel; Christian Rose; Norbert Vey; Daniela Gioia; Dario Ferrero; Gianluca Gaidano; Giovanni Cametti; Fabrizio Pane; Alessandro Sanna; Ulrich Germing; Guillermo F Sanz; François Dreyfus; Pierre Fenaux
Journal:  J Clin Oncol       Date:  2017-03-28       Impact factor: 44.544

4.  Randomized versus historical controls for clinical trials.

Authors:  H Sacks; T C Chalmers; H Smith
Journal:  Am J Med       Date:  1982-02       Impact factor: 4.965

5.  Time-dependent changes in mortality and transformation risk in MDS.

Authors:  Michael Pfeilstöcker; Heinz Tuechler; Guillermo Sanz; Julie Schanz; Guillermo Garcia-Manero; Francesc Solé; John M Bennett; David Bowen; Pierre Fenaux; Francois Dreyfus; Hagop Kantarjian; Andrea Kuendgen; Luca Malcovati; Mario Cazzola; Jaroslav Cermak; Christa Fonatsch; Michelle M Le Beau; Marilyn L Slovak; Alessandro Levis; Michael Luebbert; Jaroslaw Maciejewski; Sigrid Machherndl-Spandl; Silvia M M Magalhaes; Yasushi Miyazaki; Mikkael A Sekeres; Wolfgang R Sperr; Reinhard Stauder; Sudhir Tauro; Peter Valent; Teresa Vallespi; Arjan A van de Loosdrecht; Ulrich Germing; Detlef Haase; Peter L Greenberg
Journal:  Blood       Date:  2016-06-22       Impact factor: 22.113

6.  Modeling time-to-event (survival) data using classification tree analysis.

Authors:  Ariel Linden; Paul R Yarnold
Journal:  J Eval Clin Pract       Date:  2017-07-03       Impact factor: 2.431

7.  Prognosis of patients with intermediate risk IPSS-R myelodysplastic syndrome indicates variable outcomes and need for models beyond IPSS-R.

Authors:  Christopher B Benton; Maliha Khan; David Sallman; Aziz Nazha; Graciela M Nogueras González; Jin Piao; Jing Ning; Fleur Aung; Najla Al Ali; Elias Jabbour; Tapan M Kadia; Gautam Borthakur; Farhad Ravandi; Sherry Pierce; David Steensma; Amy DeZern; Gail Roboz; Mikkael Sekeres; Michael Andreeff; Hagop Kantarjian; Rami S Komrokji; Guillermo Garcia-Manero
Journal:  Am J Hematol       Date:  2018-09-26       Impact factor: 13.265

8.  Decision tree methods: applications for classification and prediction.

Authors:  Yan-Yan Song; Ying Lu
Journal:  Shanghai Arch Psychiatry       Date:  2015-04-25

9.  Use of CHAID decision trees to formulate pathways for the early detection of metabolic syndrome in young adults.

Authors:  Brian Miller; Mark Fridline; Pei-Yang Liu; Deborah Marino
Journal:  Comput Math Methods Med       Date:  2014-04-10       Impact factor: 2.238

10.  EASIX for prediction of survival in lower-risk myelodysplastic syndromes.

Authors:  Almuth Merz; Ulrich Germing; Guido Kobbe; Jennifer Kaivers; Anna Jauch; Aleksandar Radujkovic; Manuela Hummel; Axel Benner; Maximilian Merz; Peter Dreger; Thomas Luft
Journal:  Blood Cancer J       Date:  2019-11-11       Impact factor: 11.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.